HealthInvest Partners AB Has $20.75 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

HealthInvest Partners AB lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,490 shares of the healthcare conglomerate’s stock after buying an additional 3,810 shares during the period. UnitedHealth Group makes up 9.8% of HealthInvest Partners AB’s portfolio, making the stock its 2nd biggest position. HealthInvest Partners AB’s holdings in UnitedHealth Group were worth $20,750,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in UNH. China Universal Asset Management Co. Ltd. grew its position in shares of UnitedHealth Group by 20.6% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after acquiring an additional 1,857 shares during the period. Quent Capital LLC lifted its stake in shares of UnitedHealth Group by 5.5% during the 1st quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after buying an additional 217 shares in the last quarter. EntryPoint Capital LLC bought a new stake in UnitedHealth Group during the first quarter valued at about $75,000. Rodgers Brothers Inc. raised its stake in UnitedHealth Group by 2.4% during the 1st quarter. Rodgers Brothers Inc. now owns 842 shares of the healthcare conglomerate’s stock valued at $417,000 after purchasing an additional 20 shares during the period. Finally, Guardian Capital LP boosted its stake in UnitedHealth Group by 0.9% in the 1st quarter. Guardian Capital LP now owns 56,015 shares of the healthcare conglomerate’s stock worth $27,711,000 after purchasing an additional 477 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

NYSE:UNH traded up $2.21 during trading hours on Thursday, hitting $602.71. 459,419 shares of the stock were exchanged, compared to its average volume of 3,864,309. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s fifty day moving average price is $582.52 and its 200 day moving average price is $551.60. The company has a market cap of $554.66 billion, a P/E ratio of 39.12, a P/E/G ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the previous year, the firm posted $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.39%. UnitedHealth Group’s payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on UNH shares. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. TD Cowen boosted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Barclays cut their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Finally, KeyCorp started coverage on UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price for the company. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.